← Leaderboards
Takeshi Shimamura
University Of Illinois At Chicago
$1,905,724
Attributed
$1,905,724
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $428.4K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,905,724 · 1
By mechanism
R01$1,905,724 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Robert Andrew Winn$17,137,083
- R John Solaro$27,541,486
- Jeffrey A Sosman$7,988,701
- Andrei V Karginov$8,657,445
- Arun K Ghosh$14,662,368
Others in their field
Other Emerging Leaders on “Epithelial Cells”
- Gary Fanger · Rise Therapeutics, Llc$15,902,290
- Jakob H. Von Moltke · University Of Washington$8,146,800
- Shruti Naik · New York University School Of Medicine$6,937,612
- Birgit Schilling · Medical College Of Wisconsin$6,423,173
- Elizabeth Ann Sugar · Johns Hopkins University$6,288,276
- Nicholas Arpaia · Columbia Univ New York Morningside$6,241,249
Research focus
Epithelial CellsAutocrineBiological MarkersAutomobile DrivingBiologyBeta-ArrestinCancer ModelCancer PatientCancer TherapyBiological ProcessCell Culture TechniquesCell LineCellsChemokine ReceptorClinical ResearchComplexCxc ChemokinesDrug ResistanceDrug TargetingDrug ToleranceEffective TherapyEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorEpithelial To Mesenchymal Transition
Grant awards (5)
Investigation of CXCR7 signaling in EGFR TKI resistant NSCLC$350,981
R01 · FY2023 · CA · contact PI
Investigation of CXCR7 signaling in EGFR TKI resistant NSCLC$351,825
R01 · FY2022 · CA · contact PI
Investigation of CXCR7 signaling in EGFR TKI resistant NSCLC$367,620
R01 · FY2021 · CA · contact PI
Investigation of CXCR7 signaling in EGFR TKI resistant NSCLC$406,922
R01 · FY2020 · CA · contact PI
Investigation of CXCR7 signaling in EGFR TKI resistant NSCLC$428,376
R01 · FY2019 · CA · contact PI